These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 6613796)

  • 21. [Effect of clofibrate on lipoprotein-lipids in patients with type IV hyperlipoproteinaemia (author's transl)].
    Weisweiler P; Schwandt P
    Klin Wochenschr; 1977 Aug; 55(16):791-4. PubMed ID: 198601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dietary aspects of hyperlipidemia.
    Gotto AM; Scott L
    J Am Diet Assoc; 1973 Jun; 62(6):617-25. PubMed ID: 4350194
    [No Abstract]   [Full Text] [Related]  

  • 23. Gemfibrozil treatment: a comparison with clofibrate.
    Howard AN; Ghosh P
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):88-9. PubMed ID: 190609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Type IV hyperlipoproteinaemia.
    Kwiterovich PO; Margolis S
    Clin Endocrinol Metab; 1973 Mar; 2(1):41-71. PubMed ID: 4359117
    [No Abstract]   [Full Text] [Related]  

  • 25. Current status of the nosology of the hyperlipidemias.
    Bilheimer DW
    Birth Defects Orig Artic Ser; 1978; 14(6B):47-67. PubMed ID: 215244
    [No Abstract]   [Full Text] [Related]  

  • 26. Pathogenesis of alcoholic hypertriglyceridemia and hypercholesterolemia.
    Baraona E; Savolainen M; Karsenty C; Leo MA; Lieber CS
    Trans Assoc Am Physicians; 1983; 96():306-15. PubMed ID: 6687299
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of rapid screening methods for the detection of abnormal lipid states related to atherosclerosis.
    Boyle E; Dash HH; Owen D; Yarmosh D
    Ann Clin Lab Sci (1971); 1972; 2(5):393-403. PubMed ID: 4343280
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparative treatment of hyperlipoproteinaemias in chimpanzees.
    Vastesaeger M; Blaton V; Declercq B; Vercruysse J; Vandamme D; Peeters H; Mortelmans J
    Acta Zool Pathol Antverp; 1974; 58(0):79-96. PubMed ID: 4365833
    [No Abstract]   [Full Text] [Related]  

  • 29. [Long-term treatment of hyperlipoproteinaemia, types IIa and IIb, with etiroxate (author's transl)].
    Schwartzkopff W; Russ E
    Dtsch Med Wochenschr; 1975 Apr; 100(15):815-21. PubMed ID: 164334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atilipidemic drugs. Part 5: Evaluation of the hypolipidemic effect of LF 178 in 191 patients affected by the atherogenic form of endogenous hyperlipoproteinemia (types IIa, IIb and IV).
    Rouffy J; Dreux C; Goussault Y; Dakkak R; Renson FJ
    Arzneimittelforschung; 1976; 26(5):901-6. PubMed ID: 183788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Familial hyperlipidemias. Diagnosis and treatment.
    Fleischmajer R; Dowlati Y; Reeves JR
    Arch Dermatol; 1974 Jul; 110(1):43-50. PubMed ID: 4371196
    [No Abstract]   [Full Text] [Related]  

  • 32. [Multicenter clinical, double blind, and randomized study to assess the effectiveness and safety of binifibrate versus gemfibrozil in type IIa, IIb, and IV hyperlipidemia].
    Corominas Vilardell A; de Oya Otero M; Escobar Jiménez F; Anguera Vila A; Ariño Armengol B
    An Med Interna; 1993 Nov; 10(11):537-41. PubMed ID: 8117868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Disorders of the metabolism of serum lipoproteins].
    Tayeau F
    Bull Mem Acad R Med Belg; 1977; 132(9):502-16. PubMed ID: 206301
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of a new synthetic compound (3-nicotinoyl-oxypropyl p-chlorophenoxy isobutyrate: I.612) on plasma lipids in patients with type IIa, IIb and IV hyperdyslipidemia].
    Bucalossi A; Buzzelli G; D'Alessandro A
    Clin Ter; 1979 Apr; 89(2):127-49. PubMed ID: 226307
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of a clofibrate-inositol nicotinate combination on lipids and lipoproteins in primary hyperlipoproteinemia of types IIa, IV and V].
    Hutt V; Wechsler JG; Klör HU; Ditschuneit H
    Arzneimittelforschung; 1983; 33(5):776-9. PubMed ID: 6683558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Should hyperlipidemia be treated? Available agents and clinical results.
    Gotto AM
    Cardiovasc Res Cent Bull; 1978; 17(1):3-27. PubMed ID: 223761
    [No Abstract]   [Full Text] [Related]  

  • 37. Antilipidemic drugs. Part 6: LF 178 in man. A preliminary note on a multicenter investigation bearing on 393 subjects with pure or mixed forms of hyperlipidemia.
    Wülfert B; Majoie B; de Ceaurriz A
    Arzneimittelforschung; 1976; 26(5):906-9. PubMed ID: 183789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The lipid hypothesis. Genetic basis.
    Glueck CJ; Kwiterovich PO
    Arch Surg; 1978 Jan; 113(1):35-41. PubMed ID: 202221
    [No Abstract]   [Full Text] [Related]  

  • 39. Lipoproteins and hyperlipoproteinaemia.
    Rifkind BM
    Clin Endocrinol Metab; 1973 Mar; 2(1):3-10. PubMed ID: 4359116
    [No Abstract]   [Full Text] [Related]  

  • 40. Management of hyperlipidemias.
    Murphy BF
    JAMA; 1974 Dec 23-30; 230(12):1683-91. PubMed ID: 4373590
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.